These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31721910)

  • 1. Ethical issues surrounding breast cancer screening in Brazil.
    Gonçalves R; Soares-Jr JM; Baracat EC; Filassi JR
    Clinics (Sao Paulo); 2019; 74():e1573. PubMed ID: 31721910
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on duty of candour and cancer screening.
    Given-Wilson R
    Br J Radiol; 2018 Oct; 91(1090):20170451. PubMed ID: 28707540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer screening.
    Vanderburgh D
    Politics Life Sci; 2018; 37(1):135-140. PubMed ID: 29717961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much is too much breast screening?
    Torjesen I
    BMJ; 2015 Jan; 350():h139. PubMed ID: 25588758
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer screening among women with intellectual disability.
    Bouchardy Magnin C
    Soz Praventivmed; 2004; 49(6):361-2. PubMed ID: 15669435
    [No Abstract]   [Full Text] [Related]  

  • 6. Is now the right time to abolish breast cancer screening in Hong Kong?
    Chow LC
    Hong Kong Med J; 2018 Jun; 24(3):216-217. PubMed ID: 29926791
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Breast Cancer Screening Scenario in Brazil.
    Tiezzi DG; Orlandini FL; Carrara HHA; Cândido Dos Reis FJ; Andrade JM
    Rev Bras Ginecol Obstet; 2019 Nov; 41(11):633-635. PubMed ID: 31745955
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal.
    Martei YM; Dauda B; Vanderpuye V
    BMC Cancer; 2022 Feb; 22(1):203. PubMed ID: 35197002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's participation in breast cancer screening in France--an ethical approach.
    Moutel G; Duchange N; Darquy S; de Montgolfier S; Papin-Lefebvre F; Jullian O; Viguier J; Sancho-Garnier H;
    BMC Med Ethics; 2014 Aug; 15():64. PubMed ID: 25127662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on prevention and screening for breast cancer in Hong Kong.
    Lam TH; Wong KH; Chan KK; Chan MC; Chao DV; Cheung AN; Fan CY; Ho J; Hui EP; Lam KO; Law CK; Law WL; Loong HH; Ngan RK; Tsang TH; Wong MC; Yeung RM; Ying AC; Ching R
    Hong Kong Med J; 2018 Jun; 24(3):298-306. PubMed ID: 29926793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding breast cancer screening: should the intellectually non-disabled make decisions for the intellectually disabled?
    Mühlhauser I
    Soz Praventivmed; 2004; 49(6):359-60. PubMed ID: 15669434
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical concerns arising from screening procedures such as mammography and self-referral.
    Faulkner K
    Radiat Prot Dosimetry; 2009 Jul; 135(2):90-4. PubMed ID: 19234319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ethical considerations in the evolution of organised cancer screening programs].
    Jullian O; Darquy S; Moutel G; Duchange N
    Rev Prat; 2019 Jan; 69(1):107-109. PubMed ID: 30983298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of breast cancer screening among younger women in the Barretos Region, Brazil.
    De Castro Mattos JS; Mauad EC; Syrjänen K; Longatto-Filho A; Haikel RL; Da Costa Vieira RA; Silva TB; De Barros N
    Anticancer Res; 2013 Jun; 33(6):2651-5. PubMed ID: 23749923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women's Cancer: Points to Consider.
    Lévesque E; Kirby E; Bolt I; Knoppers BM; de Beaufort I; Pashayan N; Widschwendter M
    Public Health Genomics; 2018; 21(1-2):37-44. PubMed ID: 30223261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abolishing mammography screening programs? A view from the Swiss Medical Board.
    Biller-Andorno N; Jüni P
    N Engl J Med; 2014 May; 370(21):1965-7. PubMed ID: 24738641
    [No Abstract]   [Full Text] [Related]  

  • 19. The performance of mobile screening units in a breast cancer screening program in Brazil.
    Greenwald ZR; Fregnani JH; Longatto-Filho A; Watanabe A; Mattos JSC; Vazquez FL; Franco EL
    Cancer Causes Control; 2018 Feb; 29(2):233-241. PubMed ID: 29250701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysing the ethics of breast cancer overdiagnosis: a pathogenic vulnerability.
    Rogers WA
    Med Health Care Philos; 2019 Mar; 22(1):129-140. PubMed ID: 30030748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.